Dynamic changes in peripheral blood monocytes early after anti-PD-1 therapy predict clinical outcomes in hepatocellular carcinoma

Immune checkpoint inhibitors are effective for advanced hepatocellular carcinoma (HCC), but there remains a need for peripheral blood biomarkers to predict the clinical response. Here, we analyzed the peripheral blood of 45 patients with advanced HCC who underwent nivolumab. During treatment, freque...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeon, Seung Hyuck, Lee, Yong Joon, Kim, Hyung-Don, Nam, Heejin, Ryoo, Baek-Yeol, Park, Su-Hyung, Yoo, Changhoon, Shin, Eui-Cheol
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9333050/
https://www.ncbi.nlm.nih.gov/pubmed/35902399
http://dx.doi.org/10.1007/s00262-022-03258-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9333050/
https://www.ncbi.nlm.nih.gov/pubmed/35902399
http://dx.doi.org/10.1007/s00262-022-03258-6

Ejemplares similares